Why the study?
Does the Virochip platform improve viral detection in adults with respiratory tract infections compared to conventional methods?
Does the Virochip platform improve viral detection in adults with respiratory tract infections compared to conventional methods?
The Virochip microarray platform offers superior viral detection rates compared to culture and reveals significant diversity in human coronaviruses and rhinoviruses in respiratory infections.
Answers are grounded in this paper and cite their sources.
May enhance respiratory virus detection over culture; leaves open whether it improves outcomes or warrants adoption.
BACKGROUND: Between 50% and 80% of asthma exacerbations are associated with viral respiratory tract infections (RTIs), yet the influence of viral pathogen diversity on asthma outcomes is poorly understood because of the limited scope and throughput of conventional viral detection methods. METHODS: We investigated the capability of the Virochip, a DNA microarray-based viral detection platform, to characterize viral diversity in RTIs in adults with and without asthma. RESULTS: The Virochip detected viruses in a higher proportion of samples (65%) than did culture isolation (17%) while exhibiting high concordance (98%) with and comparable sensitivity (97%) and specificity (98%) to pathogen-specific polymerase chain reaction. A similar spectrum of viruses was identified in the RTIs of each patient subgroup; however, unexpected diversity among human coronaviruses (HCoVs) and human rhinoviruses (HRVs) was revealed. All but one of the HCoVs corresponded to the newly recognized HCoV-NL63 and HCoV-HKU1 viruses, and >20 different serotypes of HRVs were detected, including a set of 5 divergent isolates that formed a distinct genetic subgroup. CONCLUSIONS: The Virochip can detect both known and novel variants of viral pathogens present in RTIs. Given the diversity detected here, larger-scale studies will be necessary to determine whether particular substrains of viruses confer an elevated risk of asthma exacerbation.
No takes yet. Share an insight, caveat, or question.
Kistler et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: